XTX Topco’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Buy
131,425
+98,262
+296% +$751K 0.02% 1413
2025
Q4
$322K Buy
+33,163
New +$282K 0.01% 2008
2025
Q3
Sell
-62,794
Closed -$583K 3149
2025
Q2
$583K Buy
+62,794
New +$548K 0.02% 991
2025
Q1
Sell
-11,337
Closed -$137K 2985
2024
Q4
$137K Buy
+11,337
New +$138K 0.01% 1694
2024
Q3
Sell
-14,505
Closed -$131K 2512
2024
Q2
$131K Sell
14,505
-3,170
-18% -$22.1K 0.01% 1356
2024
Q1
$144K Buy
+17,675
New +$145K 0.02% 1270
2023
Q4
Sell
-12,387
Closed -$212K 2037
2023
Q3
$212K Buy
+12,387
New +$243K 0.04% 982
2023
Q2
Sell
-24,557
Closed -$434K 1765
2023
Q1
$434K Buy
24,557
+16,754
+215% +$398K 0.09% 382
2022
Q4
$212K Buy
+7,803
New +$162K 0.05% 806

Other funds holding REPL

XTX Topco's REPL Position: Q1 2026 in Review

XTX Topco increased its Replimune Group (REPL) stake by 296% in Q1 2026, buying an estimated $751K and bringing the position to 131,425 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #1413.

XTX Topco first reported a position in REPL in Q4 2022 and has held it in 9 quarters since. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • XTX Topco held 131,425 shares of Replimune Group worth $1.01M as of Q1 2026.
  • XTX Topco bought 98,262 Replimune Group shares in Q1 2026, an estimated $751K.
  • Replimune Group made up 0.02% of XTX Topco's portfolio in Q1 2026, its #1413 holding.
  • XTX Topco first reported a position in Replimune Group in Q4 2022 and has held it in 9 quarters since.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.